The DOI matches its Crossref record; 245 of the 245 references it cites were found in a registry or an index.
Chemotherapy: a double-edged sword in cancer treatment
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Tajmohammadi, I., Mohammadian, J., Sabzichi, M., Mahmuodi, S., Ramezani, M., Aghajani, M., & Ramezani, F. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28678 · Cited by 19
RetractedMa, Z., Bao, X., & Gu, J. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.12.027 · Cited by 10
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Nishita, M., Park, S.-Y., Nishio, T., Kamizaki, K., Wang, Z., Tamada, K., Takumi, T., Hashimoto, R., Otani, H., Pazour, G. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-016-0028-x · Cited by 15,947
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Rakita, A., Nikolić, N., Mildner, M., Matiasek, J., & Elbe-Bürger, A. (2020) · Scientific Reports · doi:10.1038/s41598-019-56847-4 · Cited by 8,228
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Cancer and Radiation Therapy: Current Advances and Future Directions
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K.-W. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.3635 · Cited by 2,880
EMT Transition States during Tumor Progression and Metastasis
Pastushenko, I., & Blanpain, C. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.12.001 · Cited by 2,876
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
ROS in cancer therapy: the bright side of the moon
Perillo, B., Di Donato, M., Pezone, A., Di Zazzo, E., Giovannelli, P., Galasso, G., Castoria, G., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0384-2 · Cited by 2,176
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
A History of Cancer Chemotherapy
DeVita, V. T., & Chu, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6611 · Cited by 1,970
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.041 · Cited by 1,883
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Inflammation 2010: New Adventures of an Old Flame
Medzhitov, R. (2010) · Cell · doi:10.1016/j.cell.2010.03.006 · Cited by 1,834
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
Doxorubicin pathways: pharmacodynamics and adverse effects
Thorn, C. F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833ffb56 · Cited by 1,648
How Taxol/paclitaxel kills cancer cells
Weaver, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0916 · Cited by 1,547
Immunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Cellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Itzkowitz, S. H., & Yio, X. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2004 · Cited by 1,274
Induction of Apoptosis by Cancer Chemotherapy
Kaufmann, S. H., & Earnshaw, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4838 · Cited by 1,266
NF-κB, an Active Player in Human Cancers
Xia, Y., Shen, S., & Verma, I. M. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0112 · Cited by 1,213
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.350 · Cited by 1,204
NF-κB and STAT3 – key players in liver inflammation and cancer
He, G., & Karin, M. (2011) · Cell Research · doi:10.1038/cr.2010.183 · Cited by 1,197
Inflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184
Detection of immunogenic cell death and its relevance for cancer therapy
Fucikova, J., Kepp, O., Kasikova, L., Petroni, G., Yamazaki, T., Liu, P., Zhao, L., Spisek, R., Kroemer, G., & Galluzzi, L. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03221-2 · Cited by 1,138
Hoff, P. M., Ansari, R., Batist, G., Cox, J., Kocha, W., Kuperminc, M., Maroun, J., Walde, D., Weaver, C., Harrison, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2282 · Cited by 1,130
TNF and ROS crosstalk in inflammation
Blaser, H., Dostert, C., Mak, T. W., & Brenner, D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.002 · Cited by 1,008
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., & Ostrand-Rosenberg, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2587 · Cited by 949
Bracci, L., Schiavoni, G., Sistigu, A., & Belardelli, F. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.67 · Cited by 928
Reactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Emens, L. A., & Middleton, G. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0064 · Cited by 831
Tumor microenvironment: Sanctuary of the devil
Hui, L., & Chen, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.039 · Cited by 779
Tumor necrosis factor and cancer, buddies or foes?
Wang, X., & Lin, Y. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00889.x · Cited by 730
Hypoxia: A key regulator of angiogenesis in cancer
Liao, D., & Johnson, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9066-y · Cited by 721
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Owen, K. L., Brockwell, N. K., & Parker, B. S. (2019) · Cancers · doi:10.3390/cancers11122002 · Cited by 714
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Gregory, A. D., & McGarry Houghton, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2583 · Cited by 707
Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H., & Kuwano, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4015 · Cited by 696
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Serafini, P., Mgebroff, S., Noonan, K., & Borrello, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6621 · Cited by 673
The Role of Angiogenesis in Cancer Treatment
Rajabi, M., & Mousa, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020034 · Cited by 656
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Molon, B., Ugel, S., Del Pozzo, F., Soldani, C., Zilio, S., Avella, D., De Palma, A., Mauri, P., Monegal, A., Rescigno, M., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101956 · Cited by 650
Cisplatin nephrotoxicity: a review of the literature
Manohar, S., & Leung, N. (2018) · Journal of Nephrology · doi:10.1007/s40620-017-0392-z · Cited by 636
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shalapour, S., Font-Burgada, J., Di Caro, G., Zhong, Z., Sanchez-Lopez, E., Dhar, D., Willimsky, G., Ammirante, M., Strasner, A., Hansel, D. E., et al. (2015) · Nature · doi:10.1038/nature14395 · Cited by 611
The Two Faces of Reactive Oxygen Species in Cancer
Reczek, C. R., & Chandel, N. S. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-041916-065808 · Cited by 602 · cited 2×
“Also, NF-kB / NRF2 transcription factors prevent cancer cell death by inducing the expression of antioxidants [120].”
BackgroundThe involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
Apte, R. N., Dotan, S., Elkabets, M., White, M. R., Reich, E., Carmi, Y., Song, X., Dvozkin, T., Krelin, Y., & Voronov, E. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9004-4 · Cited by 593
Penrose, R. (2004) · Cited by 591
Ostrand-Rosenberg, S., Sinha, P., Beury, D. W., & Clements, V. K. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.011 · Cited by 583
Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., Gritsko, T., Turkson, J., Kay, H., Semenza, G. L., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208719 · Cited by 576
Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease
Munkholm, P. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.18.s2.2.x · Cited by 566
Pan, P.-Y., Ma, G., Weber, K. J., Ozao-Choy, J., Wang, G., Yin, B., Divino, C. M., & Chen, S.-H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1882 · Cited by 467
Fates of CD8+ T cells in Tumor Microenvironment
Maimela, N. R., Liu, S., & Zhang, Y. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.11.004 · Cited by 459
The relationship between COPD and lung cancer
Durham, A. L., & Adcock, I. M. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.08.017 · Cited by 451
Weng, Y.-S., Tseng, H.-Y., Chen, Y.-A., Shen, P.-C., Al Haq, A. T., Chen, L.-M., Tung, Y.-C., & Hsu, H.-L. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0988-0 · Cited by 444
Tumor associated macrophages and neutrophils in tumor progression
Galdiero, M. R., Garlanda, C., Jaillon, S., Marone, G., & Mantovani, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24260 · Cited by 440
Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
Hanson, E. M., Clements, V. K., Sinha, P., Ilkovitch, D., & Ostrand-Rosenberg, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804253 · Cited by 427
Pang, B., Qiao, X., Janssen, L., Velds, A., Groothuis, T., Kerkhoven, R., Nieuwland, M., Ovaa, H., Rottenberg, S., van Tellingen, O., et al. (2013) · Nature Communications · doi:10.1038/ncomms2921 · Cited by 420
Role of the NLRP3 inflammasome in cancer
Moossavi, M., Parsamanesh, N., Bahrami, A., Atkin, S. L., & Sahebkar, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0900-3 · Cited by 417
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Nagaraj, S., Schrum, A. G., Cho, H.-I., Celis, E., & Gabrilovich, D. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902661 · Cited by 414
Mechanistic links between COPD and lung cancer
Houghton, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3477 · Cited by 414
De Larco, J. E., Wuertz, B. R. K., & Furcht, L. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0760 · Cited by 412
Inflammation and Lung Cancer: Roles of Reactive Oxygen/Nitrogen Species
Azad, N., Rojanasakul, Y., & Vallyathan, V. (2008) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400701436460 · Cited by 409
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Qin, J.-J., Yan, L., Zhang, J., & Zhang, W.-D. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1206-z · Cited by 396
Role of STAT3 in Cancer Metastasis and Translational Advances
Kamran, M. Z., Patil, P., & Gude, R. P. (2013) · BioMed Research International · doi:10.1155/2013/421821 · Cited by 393
Inflammation and Liver Cancer: New Molecular Links
Berasain, C., Castillo, J., Perugorria, M. J., Latasa, M. U., Prieto, J., & Avila, M. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03704.x · Cited by 390
Migratory neighbors and distant invaders: tumor-associated niche cells
Wels, J., Kaplan, R. N., Rafii, S., & Lyden, D. (2008) · Genes & Development · doi:10.1101/gad.1636908 · Cited by 381
Alexandre, J., Hu, Y., Lu, W., Pelicano, H., & Huang, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3914 · Cited by 380
IL‐1 and IL‐1 regulatory pathways in cancer progression and therapy
Mantovani, A., Barajon, I., & Garlanda, C. (2018) · Immunological Reviews · doi:10.1111/imr.12614 · Cited by 376
Cancer stem cells: The root of tumor recurrence and metastases
Peitzsch, C., Tyutyunnykova, A., Pantel, K., & Dubrovska, A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.011 · Cited by 372
Wu, X., Tao, P., Zhou, Q., Li, J., Yu, Z., Wang, X., Li, J., Li, C., Yan, M., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15119 · Cited by 367
Strategies and Approaches of Targeting STAT3 for Cancer Treatment
Furtek, S. L., Backos, D. S., Matheson, C. J., & Reigan, P. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00945 · Cited by 347
The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis
Liang, W., & Ferrara, N. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0313 · Cited by 347
The role of STAT3 in leading the crosstalk between human cancers and the immune system
Wang, Y., Shen, Y., Wang, S., Shen, Q., & Zhou, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.12.003 · Cited by 340
T helper 17 cells play a critical pathogenic role in lung cancer
Chang, S. H., Mirabolfathinejad, S. G., Katta, H., Cumpian, A. M., Gong, L., Caetano, M. S., Moghaddam, S. J., & Dong, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319051111 · Cited by 326
Goulet, C. R., Champagne, A., Bernard, G., Vandal, D., Chabaud, S., Pouliot, F., & Bolduc, S. (2019) · BMC Cancer · doi:10.1186/s12885-019-5353-6 · Cited by 322
Continuous scanning for Bragg coherent X-ray imaging
Li, N., Dupraz, M., Wu, L., Leake, S. J., Resta, A., Carnis, J., Labat, S., Almog, E., Rabkin, E., Favre-Nicolin, V., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69678-5 · Cited by 321
Notarbartolo, M., Poma, P., Perri, D., Dusonchet, L., Cervello, M., & D'Alessandro, N. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.051 · Cited by 317
Immunogenic effects of chemotherapy-induced tumor cell death
Wang, Y.-J., Fletcher, R., Yu, J., & Zhang, L. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.003 · Cited by 314
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy
Pusztai, L., Mendoza, T. R., Reuben, J. M., Martinez, M. M., Willey, J. S., Lara, J., Syed, A., Fritsche, H. A., Bruera, E., Booser, D., et al. (2004) · Cytokine · doi:10.1016/j.cyto.2003.10.004 · Cited by 312
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
Vyas, D., Laput, G., & Vyas, A. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s60114 · Cited by 310
Chemotherapy induced DNA damage response: Convergence of drugs and pathways
Woods, D., & Turchi, J. J. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23761 · Cited by 296
Highlighted STAT3 as a potential drug target for cancer therapy
Lee, H., Jeong, A. J., & Ye, S.-K. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.7.152 · Cited by 295
WANG, S., KOTAMRAJU, S., KONOREV, E., KALIVENDI, S., JOSEPH, J., & KALYANARAMAN, B. (2002) · Biochemical Journal · doi:10.1042/bj20020752 · Cited by 286
Reactive oxygen species: a volatile driver of field cancerization and metastasis
Liao, Z., Chua, D., & Tan, N. S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0961-y · Cited by 284
IL-1 Family Members in Cancer; Two Sides to Every Story
Baker, K. J., Houston, A., & Brint, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01197 · Cited by 284
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
Xiong, A., Yang, Z., Shen, Y., Zhou, J., & Shen, Q. (2014) · Cancers · doi:10.3390/cancers6020926 · Cited by 283
Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation
Gewirtz, D. A., Holt, S. E., & Elmore, L. W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.024 · Cited by 281
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
Apetoh, L., Ladoire, S., Coukos, G., & Ghiringhelli, F. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv209 · Cited by 280
Unraveling the Role of Angiogenesis in Cancer Ecosystems
Zuazo-Gaztelu, I., & Casanovas, O. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00248 · Cited by 275
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
Polk, A., Vistisen, K., Vaage-Nilsen, M., & Nielsen, D. L. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-47 · Cited by 267
Nafees, S., Rashid, S., Ali, N., Hasan, S. K., & Sultana, S. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.02.021 · Cited by 265
The Inflammation and Liver Cancer
Bishayee, A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-0348-0837-8_16 · Cited by 255
Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times
Bailly, C., Thuru, X., & Quesnel, B. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa002 · Cited by 249
Calviello, G., Di Nicuolo, F., Gragnoli, S., Piccioni, E., Serini, S., Maggiano, N., Tringali, G., Navarra, P., Ranelletti, F. O., & Palozza, P. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh265 · Cited by 244
Zhang, X., Hu, F., Li, G., Li, G., Yang, X., Liu, L., Zhang, R., Zhang, B., & Feng, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0176-3 · Cited by 243
Nowak, A. K., Robinson, B. W. S., & Lake, R. (2002) · PubMed · Cited by 238
p53 Regulation of the IGF-1/AKT/mTOR Pathways and the Endosomal Compartment
Feng, Z. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001057 · Cited by 237
Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner
Volk-Draper, L., Hall, K., Griggs, C., Rajput, S., Kohio, P., DeNardo, D., & Ran, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0067 · Cited by 234
Huang, K., Chen, Y., Zhang, R., Wu, Y., Ma, Y., Fang, X., & Shen, S. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0166-5 · Cited by 231
The role IL-1 in tumor-mediated angiogenesis
Voronov, E., Carmi, Y., & Apte, R. N. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00114 · Cited by 228
STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells
Pawlus, M. R., Wang, L., & Hu, C.-J. (2014) · Oncogene · doi:10.1038/onc.2013.115 · Cited by 226
Kondylis, V., Kumari, S., Vlantis, K., & Pasparakis, M. (2017) · Immunological Reviews · doi:10.1111/imr.12550 · Cited by 226
O'Riordan, J. M., Abdel-latif, M. M., Ravi, N., McNamara, D., Byrne, P. J., McDonald, G. S. A., Keeling, P. W. N., Kelleher, D., & Reynolds, J. V. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41338.x · Cited by 220
Wang, L., Cao, L., Wang, H., Liu, B., Zhang, Q., Meng, Z., Wu, X., Zhou, Q., & Xu, K. (2017) · Oncotarget · doi:10.18632/oncotarget.18814 · Cited by 212
The Role of IL-1β in the Early Tumor Cell–Induced Angiogenic Response
Carmi, Y., Dotan, S., Rider, P., Kaplanov, I., White, M. R., Baron, R., Abutbul, S., Huszar, M., Dinarello, C. A., Apte, R. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202769 · Cited by 209
Immune system: a double-edged sword in cancer
Lakshmi Narendra, B., Eshvendar Reddy, K., Shantikumar, S., & Ramakrishna, S. (2013) · Inflammation Research · doi:10.1007/s00011-013-0645-9 · Cited by 206
Current concepts on the role of inflammation in COPD and lung cancer
Yao, H., & Rahman, I. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.009 · Cited by 201
Qian, B.-Z., Zhang, H., Li, J., He, T., Yeo, E.-J., Soong, D. Y. H., Carragher, N. O., Munro, A., Chang, A., Bresnick, A. R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141555 · Cited by 198
PGE2 Stimulates VEGF Expression in Endothelial Cells via ERK2/JNK1 Signaling Pathways
Pai, R., Szabo, I. L., Soreghan, B. A., Atay, S., Kawanaka, H., & Tarnawski, A. S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5494 · Cited by 195
Sauter, K. A. D., Wood, L. J., Wong, J., Iordanov, M., & Magun, B. E. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.12.15540 · Cited by 194
Tulotta, C., Lefley, D. V., Freeman, K., Gregory, W. M., Hanby, A. M., Heath, P. R., Nutter, F., Wilkinson, J. M., Spicer-Hadlington, A. R., Liu, X., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2202 · Cited by 191
Arjumand, W., Seth, A., & Sultana, S. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.05.012 · Cited by 177
Wang, L., Chen, Q., Qi, H., Wang, C., Wang, C., Zhang, J., & Dong, L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3034 · Cited by 175
Sun, H.-L., Liu, Y.-N., Huang, Y.-T., Pan, S.-L., Huang, D.-Y., Guh, J.-H., Lee, F.-Y., Kuo, S.-C., & Teng, C.-M. (2007) · Oncogene · doi:10.1038/sj.onc.1210169 · Cited by 171
Ezernitchi, A. V., Vaknin, I., Cohen-Daniel, L., Levy, O., Manaster, E., Halabi, A., Pikarsky, E., Shapira, L., & Baniyash, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4763 · Cited by 169
The paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances
Houghton, A. M. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11297 · Cited by 166
Roles of neutrophils in cancer growth and progression
Galdiero, M. R., Varricchi, G., Loffredo, S., Mantovani, A., & Marone, G. (2017) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0717-292r · Cited by 166
Collins, K. D., & Stark, G. R. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91761-8 · Cited by 164
Dual role of inflammatory mediators in cancer
Shrihari, T. (2017) · ecancermedicalscience · doi:10.3332/ecancer.2017.721 · Cited by 164
Classical Chemotherapy: Mechanisms, Toxicities and the Therapeutc Window
Malhotra, V., & Perry, M. C. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.199 · Cited by 163
Cancer incidence increasing globally: The role of relaxed natural selection
You, W., & Henneberg, M. (2018) · Evolutionary Applications · doi:10.1111/eva.12523 · Cited by 163
Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide
Motoyoshi, Y., Kaminoda, K., Saitoh, O., Hamasaki, K., Nakao, K., Ishii, N., Nagayama, Y., & Eguchi, K. (2006) · Oncology Reports · doi:10.3892/or.16.1.141 · Cited by 161
Rieder, F., Biancani, P., Harnett, K. M., Yerian, L. M., & Falk, G. W. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00454.2009 · Cited by 160
Opzoomer, J. W., Sosnowska, D., Anstee, J. E., Spicer, J. F., & Arnold, J. N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01654 · Cited by 160
Chemotherapy-Induced Apoptosis
Mesner, P. W., Budihardjo, I. I., & Kaufmann, S. H. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)61069-8 · Cited by 158
The diverse roles of the TNF axis in cancer progression and metastasis.
Ham, B., Fernández, M. C., D'Costa, Z., & Brodt, P. (2016) · PubMed · Cited by 146
Soares, P. M. G., Mota, J. M., Gomes, A. S., de Oliveira, R. B., Assreuy, A. M. S., Brito, G. A. D. C., dos Santos, A. A., Ribeiro, R. A., & de Souza, M. H. L. P. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0715-9 · Cited by 144
Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?
Bagnyukova, T., Serebriiskii, I. G., Zhou, Y., Hopper-Borge, E. A., Golemis, E. A., & Astsaturov, I. A. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.9.13738 · Cited by 143
Zhang, Q., & Liu, F. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2696-5 · Cited by 142
NF-κB Signaling in Ovarian Cancer
Harrington, B. S., & Annunziata, C. M. (2019) · Cancers · doi:10.3390/cancers11081182 · Cited by 140
Huang, Y., Tsai, M., Hsieh, P.-C., Shih, J.-H., Wang, T., Wang, Y.-C., Lin, T., & Wang, S. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.05.034 · Cited by 138
Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis
Tong, D., Liu, Q., Liu, G., Xu, J., Lan, W., Jiang, Y., Xiao, H., Zhang, D., & Jiang, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.031 · Cited by 134
Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease
Al-Homsi, A. S., Roy, T. S., Cole, K., Feng, Y., & Duffner, U. A. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.08.014 · Cited by 132
Inflammation and cancer stem cells
Shigdar, S. L., Li, Y., Bhattacharya, S., O’Connor, M., Pu, C., Lin, J., Wang, T., Xiang, D., Kong, L., Wei, M. Q., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.031 · Cited by 130
The role of cancer stem cells in relapse of solid tumors
Yu, Y. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/478 · Cited by 129
Cui, Z., Shen, Y., Chen, K. H., Mittal, S. K., Yang, J., & Zhang, G. (2017) · Scientific Reports · doi:10.1038/srep46392 · Cited by 128
NF-κB: a new player in angiostatic therapy
Tabruyn, S. P., & Griffioen, A. W. (2008) · Angiogenesis · doi:10.1007/s10456-008-9094-4 · Cited by 127
NF-κB Affects Proliferation and Invasiveness of Breast Cancer Cells by Regulating CD44 Expression
Smith, S. M., Lyu, Y. L., & Cai, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106966 · Cited by 123
Cao, Y., Yu, J., Liu, T., Yang, K.-X., Yang, L.-Y., Chen, Q., Shi, F., Hao, J., Cai, Y., Wang, M., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0068-6 · Cited by 122
Liu, W., Lu, X., Shi, P., Yang, G., Zhou, Z., Li, W., Mao, X., Jiang, D., & Chen, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-58642-y · Cited by 122
The Role of Prostaglandin E 2 in Tumor-Associated Immunosuppression
Wang, D., & DuBois, R. N. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.11.003 · Cited by 114
Sevko, A., Sade-Feldman, M., Kanterman, J., Michels, T., Falk, C. S., Umansky, L., Ramacher, M., Kato, M., Schadendorf, D., Baniyash, M., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.444 · Cited by 111
Wood, L. J., Nail, L. M., Perrin, N., Elsea, C. R., Fischer, A. M., & Druker, B. J. (2006) · Biological Research For Nursing · doi:10.1177/1099800406290932 · Cited by 102
Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells
Zakaria, N., Yusoff, N. M., Zakaria, Z., Widera, D., & Yahaya, B. H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00166 · Cited by 102
Cui, X., Shen, D., Kong, C., Zhang, Z., Zeng, Y., Lin, X., & Liu, X. (2017) · Scientific Reports · doi:10.1038/srep40723 · Cited by 100
Cancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 100
Wang, S., Yu, Y., Cheng, Z., Hu, Y., & Liu, T. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0026-9 · Cited by 100
Nagaraja, A. S., Dorniak, P. L., Sadaoui, N. C., Kang, Y., Lin, T., Armaiz-Peña, G. N., Wu, S. Y., Rupaimoole, R., Allen, J. K., Gharpure, K. M., et al. (2015) · Oncogene · doi:10.1038/onc.2015.302 · Cited by 96
Excess mortality associated with three Los Angeles September hot spells
Oechsli, F. W., & Buechley, R. W. (1970) · Environmental Research · doi:10.1016/0013-9351(70)90021-6 · Cited by 95
Chakraborty, C., Sharma, A. R., Sharma, G., Sarkar, B., & Lee, S.-S. (2018) · OncoTarget · doi:10.18632/oncotarget.24309 · Cited by 95
Farhadi, A., Fields, J. Z., Banan, A., & Keshavarzian, A. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04006-0 · Cited by 93
Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection
Humanes, B., Camaño, S., de Lara, J. M. T., Sabisetti, V. S., González-Nicolás, M. Á., Bonventre, J. V., Tejedor, A., & Lázaro, A. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx005 · Cited by 90
Takeda, H., Takai, A., Inuzuka, T., & Marusawa, H. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1273-2 · Cited by 84
Wang, J., Ratnam, N. M., Byrd, J. C., & Guttridge, D. C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.049 · Cited by 82
Edwardson, D. W., Boudreau, J., Mapletoft, J., Lannér, C., Kovala, A. T., & Parissenti, A. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183662 · Cited by 82
Ma, C., Wang, F., Han, B., Zhong, X., Si, F., Ye, J., Hsueh, E. C., Robbins, L., Kiefer, S. M., Zhang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0824-y · Cited by 79
Breaking the ‘harmony’ of TNF-α signaling for cancer treatment
Sasi, S. P., Yan, X., Enderling, H., Park, D. S., Gilbert, H.-Y., Curry, C. L., Coleman, C. N., Hlatky, L., Qin, G., Kishore, R., et al. (2011) · Oncogene · doi:10.1038/onc.2011.567 · Cited by 77
Buhrmann, C., Yazdi, M., Popper, B., Kunnumakkara, A. B., Aggarwal, B. B., & Shakibaei, M. (2019) · Nutrients · doi:10.3390/nu11030704 · Cited by 75
Elsea, C. R., Roberts, D. A., Druker, B. J., & Wood, L. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002355 · Cited by 71
Mechanisms of Viral Hepatitis Induced Liver Injury
Nakamoto, Y., & Kaneko, S. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479591 · Cited by 71
Xiao, M., Cai, J., Cai, L., Jia, J., Xie, L., Zhu, Y., Huang, B., Jin, D., & Wang, Z. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0321-8 · Cited by 71
Zaynagetdinov, R., Sherrill, T. P., Gleaves, L. A., Hunt, P., Han, W., McLoed, A. G., Saxon, J. A., Tanjore, H., Gulleman, P. M., Young, L. R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6562 · Cited by 68
Ibrahim, A., Al-Hizab, F. A., Abushouk, A. I., & Abdel‐Daim, M. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01268 · Cited by 68
Su, B., Luo, T., Zhu, J., Fu, J., Zhao, X., Chen, L., Zhang, H., Ren, Y., Yu, L., Yang, X., et al. (2014) · Hepatology · doi:10.1002/hep.27551 · Cited by 67
Hamada, S., Masamune, A., Yoshida, N., Takikawa, T., & Shimosegawa, T. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-4001-5 · Cited by 67
Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin
Wong, J. W., Smith, L. B., Magun, E. A., Engstrøm, T., Kelley-Howard, K., Jandhyala, D. M., Thorpe, C. M., Magun, B. E., & Wood, L. J. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.22628 · Cited by 66
Roles of inflammation in cancer initiation progression and metastasis
Wilber, A. C. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s55 · Cited by 65
Zhou, W. Z., Chen, M., Yu, H., Zhong, Z., Cai, N., Chen, G.-Z., ZHANG, P., & Chen, J. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3229 · Cited by 63
Mao, Z., Shen, X., Dong, P., Liu, G., Pan, S., Sun, X., Hu, H., Li, P., & Huang, J. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.12.032 · Cited by 63
Coping strategies and adjustment after closed-head injury: a cluster analytical approach
Moore, A. D., Stambrook, M., & Peters, L. C. (1989) · Brain Injury · doi:10.3109/02699058909004549 · Cited by 62
Konstantinopoulos, P. A., Fountzilas, E., Pillay, K., Zerbini, L. F., Libermann, T. A., Cannistra, S. A., & Spentzos, D. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-59 · Cited by 61
Regulation of EMT by STAT3 in gastrointestinal cancer (Review)
Li, B., & Huang, C. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3846 · Cited by 61
Wijayahadi, N., Haron, M. R., Stanslas, J., & Yusuf, Z. (2007) · Journal of Chemotherapy · doi:10.1179/joc.2007.19.6.716 · Cited by 60
Guimarães, I. D. S., Ladislau, T., Tessarollo, N. G., dos Santos, D. Z., Gimba, E. R. P., Sternberg, C., Silva, I. V., & Rangel, L. B. A. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.11.007 · Cited by 60
Cited by
Bacteriophages as Solid Tumor Theragnostic Agents
Veeranarayanan, S., Azam, A. H., Kiga, K., Watanabe, S., & Cui, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010402 · Cited by 39
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Wang, W., Lian, B., Xu, C., Wang, Q., Li, Z., Zheng, N., Liu, A., Yu, J., Zhong, W., Wang, Z., et al. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100661 · Cited by 14
Metadata
- Authors
- Behranvand, N., Nasri, F., Zolfaghari Emameh, R., Khani, P., Hosseini, A., Garssen, J., & Falak, R.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2021-08-05
- Volume
- 71
- Issue
- 3
- Pages
- 507-526
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W3187419526
- Cited by
- 397
- References
- 245
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.